Company: DRTSW
Filing Date: 2025-03-12
Form Type: 20-F
Source: 0001213900-25-023187
Chunk: 95

Company: Alpha Tau Medical Ltd.
Filing Date: 2025-03-12
Form: 20-F
Item: Item 3
Chunk 95
---
 ownership and trading activities and liability
for insiders who profit from trades made in a short period of time and (3) the rules under the Exchange Act requiring the filing with
the SEC of quarterly reports on Form 10-Q containing unaudited financial and other specified information, although it is subject to Israeli
laws and regulations with regard to certain of these matters and intend to furnish comparable quarterly information on Form 6-K. In addition,
foreign private issuers are not required to file their annual report on Form 20-F until 120 days after the end of each fiscal year, while
U. S. domestic issuers that are accelerated filers are required to file their annual report on Form 10-K within 75 days after the end of
each fiscal year and U. S. domestic issuers that are large accelerated filers are required to file their annual report on Form 10-K within
60 days after the end of each fiscal year. Foreign private issuers are also exempt from Regulation FD, which is intended to prevent issuers
from making selective disclosures of material information. As a result of all of the above, you may not have the same protections afforded
to shareholders of a company that is not a foreign private issuer.

We may lose our foreign private issuer status
in the future, which could result in significant additional costs and expenses.

As discussed above, we are
a foreign private issuer, and therefore are not required to comply with all of the periodic disclosure and current reporting requirements
of the Exchange Act. The determination of foreign private issuer status is made annually on the last business day of an issuer’s
most recently completed second fiscal quarter, and, accordingly, our next determination will be made on June 30, 2025. In the future,
we would lose its foreign private issuer status if (1) more than 50% of its outstanding voting securities are owned by U. S. residents
and (2) a majority of its directors or executive officers are U. S. citizens or residents, or it fails to meet additional requirements
necessary to avoid loss of foreign private issuer status. If we lose our foreign private issuer status, we will be required to file with
the SEC periodic reports and registration statements on U. S. domestic issuer forms, which are more detailed and extensive than the forms
available to a foreign private issuer. We would also have to mandatorily comply with U. S. federal proxy requirements, and our officers,
directors and principal shareholders will become subject to the short